Navigating Biologics Market Trends: USD 408.5 BILLION IN 2023 and Boasting a CAGR of 8.25% Projections by 2030

The latest report by MarkNtel Advisors, titled “Biologics Market Report By Therapeutic Application (Oncology, Infectious Disease, Autoimmune Disease, Diabetes, Cardiovascular Diseases, Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)), By Drug Class (Recombinant Proteins, [Hormones, Cytokines], Monoclonal Antibodies, Blood & Blood Components, Cellular & Gene Therapy, Vaccines, Others), By Source (Microbes, Humans, Others (Rodents, Plants, etc.)), Others, and Region 2024-2030”, offers a comprehensive analysis of the industry, which comprises insights on the Biologics Market research report.

What is the market outlook for Biologics?

The Global Biologics Market size was valued at USD 408.5 billion in 2023 and is estimated to grow at a CAGR of around 8.25% during the forecast period 2024-30.

For an in-depth analysis, you can request a sample copy of the report: https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html                     

Major Companies Operating in the Biologics Industry:

Bristol-Myers Squibb, Pfizer, Sanofi, Janssen Biotech, Inc., Bayer AG, Merck & Co., Amgen Inc., Abbott GmbH, Novartis, AstraZeneca Plc, GlaxoSmithKline Biologicals, Moderna, Inc., Ferring Pharmaceuticals Inc., Aimmune Therapeutics, Inc., F. Hoffman La Roche, and Others

Biologics Market Report Segmentation:

By Therapeutic Application

-Oncology

-Infectious Disease

-Autoimmune Disease

-Diabetes

-Cardiovascular Diseases

-Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)

  • The Oncology segment witnessed substantial market growth during historical years.

By Drug Class

-Recombinant Proteins

–Hormones

–Cytokines

-Monoclonal Antibodies

-Blood & Blood Components

-Cellular & Gene Therapy

-Vaccines

-Others

By Source

-Microbes

-Humans

-Others (Rodents, Plants, etc.)

Learn More About the Market Report – https://www.marknteladvisors.com/research-library/global-biologics-market.html                     

Regional Insights:

  • North America: USA, Canada, Mexico
  • Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
  • Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
  • South America: Brazil, Rest of South America
  • Middle East & Africa: UAE, Saudi Arabia, South Africa, Rest of the Middle East & Africa

Global Biologics Market Opportunity: Biotechnology Techniques ‘CRISPR-Cas9’ to Revolutionize Biologics Drug Development in Future Years

The adoption of CRISPR-Cas9 technology among the Biologics drugs offering companies for research & development purposes possesses significant opportunities for market growth. This technology holds immense potential for developing next-generation biologics by correcting genetic defects or enhancing therapeutic efficacy, thus boosting the development of biologics drugs on a large scale. For instance:

In 2023, the FDA approved the first gene therapies, i.e., Casgevy and Lyfgenia, to treat Sickle Cell Disease (SCD). Casgevy is the first FDA-approved therapy using CRISPR/Cas9 to edit patients’ blood stem cells.

Hence, the adoption of CRISPR-Cas9 technology allows companies to effectively develop biologics, like gene therapies, thus holding immense potential for the growth of the Global Biologics Market in the coming years.

Ask Analyst for Customization: https://www.marknteladvisors.com/query/request-customization/global-biologics-market.html                       

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About UsMarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Reach us:

Call: +1 628 895 8081, +91 120 4278433

Email: sales@marknteladvisors.com

Visit to know more:  www.marknteladvisors.com